Tech Company Financing Transactions

Transcept Pharmaceuticals Funding Round

Apax Partners, Domain Associates and New Enterprise Associates participated in a $35 million Series C venture round for Transcept Pharmaceuticals. The financing was announced on 1/8/2004.

Transaction Overview

Announced On
1/8/2004
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series C
Proceeds Purpose
This financing will extend our runway, enabling us to more comprehensively develop our growing pipeline of products that now includes DN-101 and AQ4N, both of which we believe have the potential to address large unmet needs in cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Park Plz. 4th Floor
Boston, MA 02116
USA
Email Address
Overview
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Profile
Transcept Pharmaceuticals LinkedIn Company Profile
Social Media
Transcept Pharmaceuticals Company Twitter Account
Company News
Transcept Pharmaceuticals News
Facebook
Transcept Pharmaceuticals on Facebook
YouTube
Transcept Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Bigham
  Michael Bigham LinkedIn Profile  Michael Bigham Twitter Account  Michael Bigham News  Michael Bigham on Facebook
Chief Financial Officer
Douglas Pagán
  Douglas Pagán LinkedIn Profile  Douglas Pagán Twitter Account  Douglas Pagán News  Douglas Pagán on Facebook
Chief Medical Officer
Evan Loh
  Evan Loh LinkedIn Profile  Evan Loh Twitter Account  Evan Loh News  Evan Loh on Facebook
President
Adam Woodrow
  Adam Woodrow LinkedIn Profile  Adam Woodrow Twitter Account  Adam Woodrow News  Adam Woodrow on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2004: ZYGO venture capital transaction
Next: 1/8/2004: E4X venture capital transaction

 

Share this article

 


Where The Data Comes From

We document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary